Funding Cannabis Medical Research Should Be Priority #1 with the Elimination of 280E
The advancement and rescheduling of cannabis and the growing ubiquity of the plant in communities across the U.S. have been positive developments towards overturning draconian drug laws. But what must […]
How Will Cannabis’ Rescheduling Impact Taxes for Plant-Touching Businesses?
As the United States’ Drug Enforcement Agency (DEA) moves to reclassify cannabis as a less-dangerous substance, the most major and immediate financial impact plant-touching operators are considering is the impact […]